Retention Rate and Safety of Biosimilar CT-P13 in Rheumatoid Arthritis: Data from the Korean College of Rheumatology Biologics Registry.

Kim HA, Lee E, Lee SK, Park YB, Lee YN, Kang HJ, Shin K.

Open source

DOI
10.1007/s40259-019-00393-y
Published
2020-02-01
Container
BioDrugs
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40259-019-00393-y,
  title = {Retention Rate and Safety of Biosimilar CT-P13 in Rheumatoid Arthritis: Data from the Korean College of Rheumatology Biologics Registry.},
  author = {Kim HA and  Lee E and  Lee SK and  Park YB and  Lee YN and  Kang HJ and  Shin K.},
  year = {2020},
  journal = {BioDrugs},
  doi = {10.1007/s40259-019-00393-y},
  url = {https://doi.org/10.1007/s40259-019-00393-y}
}

RIS

TY  - JOUR
TI  - Retention Rate and Safety of Biosimilar CT-P13 in Rheumatoid Arthritis: Data from the Korean College of Rheumatology Biologics Registry.
AU  - Kim HA
AU  -  Lee E
AU  -  Lee SK
AU  -  Park YB
AU  -  Lee YN
AU  -  Kang HJ
AU  -  Shin K.
PY  - 2020
JO  - BioDrugs
DO  - 10.1007/s40259-019-00393-y
UR  - https://doi.org/10.1007/s40259-019-00393-y
ER  - 

APA

HA, K., E, L., SK, L., YB, P., YN, L., HJ, K., & K., S. (2020). Retention Rate and Safety of Biosimilar CT-P13 in Rheumatoid Arthritis: Data from the Korean College of Rheumatology Biologics Registry.. BioDrugs. https://doi.org/10.1007/s40259-019-00393-y

Source records